AstraZeneca Plc may have provided an incomplete view of efficacy data on its COVID-19 vaccine from a large scale trial in the United States, a U.S. health agency said Tuesday, in a fresh setback for the shot.
New late-stage trial data show Regeneron and Roche's antibody cocktail against COVID-19 cut hospitalisation or death by 70% versus a placebo in non-hospitalised patients, the Swiss drugmaker said on Tuesday.
Researchers wearing headlamps and protective suits race to untangle the claws and wings of bats caught up in a big net after dark in the Philippine province of Laguna.
More producers of COVID-19 vaccines should follow AstraZeneca's lead and license technology to other manufacturers, the World Health Organization's head said on Monday, as he described continuing vaccine inequity as "grotesque".
The eastern Indian state of Odisha might have to stop its coronavirus immunisation drive for four days starting at the end of March because of a shortage of vaccine doses, according to a letter to the federal government reviewed by Reuters.
Several South Korea provinces and cities continued to require coronavirus testing for foreign workers, despite a request from the national government that prompted Seoul to end its mandate amid international outcry.
Here's what you need to know about the coronavirus right now:
Vietnam has approved Russia's Sputnik V vaccine for use against COVID-19, Russia's RDIF sovereign wealth fund, which promotes the shot globally, said on Tuesday in a statement on the Sputnik V website.
Germany is extending its lockdown until April 18 and calling on citizens to stay at home for five days over the Easter holidays to try to break a third wave of the COVID-19 pandemic, Chancellor Angela Merkel said early on Tuesday.
More restrictions aimed at tackling the COVID-19 pandemic may be needed for France, if the current measures do not result in the situation improving, French epidemiologist and government scientific adviser Arnaud Fontanet told BFM TV on Tuesday.